Area of research
Cardiology and Cardiovascular Medicine · Hematology
Research interest
Research interests include Heart Failure Treatment and Management, Erythropoietin and Anemia Treatment, Iron Metabolism and Disorders, and Cardiovascular Function and Risk Factors.
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)
Optimized heart failure therapy in patients with very advanced cancer in palliative care: dosing strategies from the EMPATICC trial
Randomized Investigation of Heart Failure Therapy in Patients with Advanced Cancer at Risk of Cardiac Wasting: Rationale and Design of the EMPATICC Trial
Intravenous Ferric Carboxymaltose in Heart Failure with Iron Deficiency (FAIR-HF2 DZHK05 trial): Sex-Specific Outcomes
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trial
Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF2-DZHK05) trial: Baseline Characteristics and Comparison to Other Relevant Clinical Trials
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip
Percutaneous Repair of Moderate-to-Severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE-HF2 Trial and Comparison to COAPT and MITRA-FR Trials
Randomized Investigation of the MitraClip Device in Heart Failure: Design and Rationale of the RESHAPE-HF2 Trial Design
Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR